Phase II study of docetaxel, cisplatin and capecitabine as preoperative chemotherapy in resectable gastric cancer

AIM: To investigate the feasibility of preoperative docetaxel, cisplatin and capecitabine (DCC) in patients with resectable gastric cancer. METHODS: Patients with resectable gastric cancer fulfilling the inclusion criteria, were treated with 4 cycles of docetaxel (60 mg/m(2)), cisplatin (60 mg/m(2))...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:World J Gastrointest Surg
Glavni autori: Dassen, Anneriet E, Bernards, Nienke, Lemmens, Valery E P P, van de Wouw, Yes A J, Bosscha, Koop, Creemers, Geert-Jan, Pruijt, Hans J F M
Format: Artigo
Jezik:Inglês
Izdano: Baishideng Publishing Group Inc 2016
Teme:
Clinical Trials Study
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5081553/
https://ncbi.nlm.nih.gov/pubmed/27830043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4240/wjgs.v8.i10.706
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items